Market close: Tourism Holdings leads way after profit turnaround
The New Zealand sharemarket finished the day higher after a late surge.
AdvertisementAdvertise with NZME.
Latest fromFisher and Paykel Healthcare
NZ Inc makes big push in India with business delegation
New Zealand will send one of its largest business delegations to India next week.
Jarden Brief: Meta on a Quest for new VR subscription service
VR attempt to curb the recent trajectory of multi-billion operating loss.
Post-Covid reality check? F&P Healthcare profit drops 34pc
F&P Healthcare's earnings have fallen to more normal levels after a big Covid-surge.
Who’s in the running to handle possible Auckland Airport share sale?
Meanwhile, details emerge of Virgin Australia's re-listing plans.
Markets with Madison: Analysts eyeing Fisher & Paykel hit, upside for aged care
FPH is extraordinarily overvalued, Forsyth Barr says.
Jarden Brief: Chip war heats up as US-China competition sparks strict new rules
Restrictions part of US effort to impede Beijing’s ambitions while ensuring stable supply.
F&P Healthcare shares soar on revenue guidance
Flu season and China Covid outbreak boosts demand.
Market close: NZ stocks rise on back of big Wall St turnaround
An energetic Fisher and Paykel Healthcare led the way.
Fisher & Paykel Healthcare to spend $275m on Karaka land for campus
"We need more space": Mega-development will roll out over decades.
F&P Healthcare expects sharp first half profit fall, shares plummet
F&P Healthcare sees earnings returning to pre-Covid levels in the first half to September.
Covid-19 had a profound impact on F&P Healthcare, says CEO
Fisher & Paykel Healthcare's net profit dropped by 28 per cent to more normal levels.
F&P Healthcare net profit drops 28pc
The healthcare manufacturer withholds guidance for current year.
Result preview: What to expect from F&P Healthcare
F&P Healthcare is expected to report a sharp fall in annual net profit on Wednesday.
Market close: Investors offload Ryman, F&P Healthcare shares
The New Zealand sharemarket opened the week with more than a 1 per cent fall.
F&P Healthcare share price drops after revenue guidance
The previous year's revenue came to $1.97b.
Deloitte Top 200 Award finalists named
The best of business in New Zealand set to be honoured in the annual Top 200 awards.
F&P Healthcare H1 profit down 2%, beats market expectations
Fisher & Paykel Healthcare has released its first half result.
Preview: What to expect from F&P Healthcare's first-half result
Market's attention will be on what lies ahead as more countries come to grips with Covid.
F&P Healthcare's revenue edged back from Covid highs
F&P Healthcare's turnover edged lower in the first four months of its financial year.
Strong start to annual results fails to lift NZ sharemarket
For the second day running, the New Zealand sharemarket was driven down by F&P Healthcare.
Brokers' Picks: The best and worst performing shares at mid-year point
Mid-year results in the Herald Brokers Picks game don't all reflect the NZX-50 returns.
F&P Healthcare's shares plunge after record $524m profit
The respiratory products maker recorded a record profit of more than $500m.
Opinion: The exposures facing healthcare sector growth
F&P Healthcare and Ryman have been standouts among Australasian healthcare companies.
Epsom double killings: The family at the centre of a tragedy
Loving family photo shared online weeks before killings.
NZ imports fell sharply in 2020 - Stats NZ
NZ's imports plummeted in 2020 while exports remained strong, Stats NZ says.
Pandemic profits: F&P Healthcare shares climb on profit upgrade
New Zealand's largest listed company upgrades full-year profit again.
Brokers' Picks: The hot stocks to watch in 2021
Brokers select their top five companies for 2021 in our annual stock picking game.
Deloitte Top 200: Company of the year overcomes adversity of 2020
Fisher & Paykel Healthcare reaps rewards.
Analysts ponder F&P Healthcare in a post-Covid world
F&P Healthcare's first-half profit leapt by 86 per cent, driven by Covid-19 demand.
Liam Dann: Despite vaccine news, war is far from over
Vaccine is no silver bullet but at least brings the horizons of this crisis into focus.
Market close: NZ shares end firmer, while FPH and a2 Milk ease
Trade thinned out before the long Labour Day weekend.